PRNP and prion disease: Experiments using animal or cellular model systems have led to proposals of several possible non-PrP mechanisms of toxicity in prion diseases, involving PrP binding partners on the cell surface and downstream intracellular changes [15–17]; however, their relevance to the human diseases is yet to be determined.